Tern Plc Wyld Networks US$1.7 million purchase orders

TERN

Tern Plc (LON:TERN), the company focused on value creation from Internet of Things technology businesses, has noted that Wyld Networks AB has announced that it has received purchase orders for its Wyld Connect IoT modules with a total value of US$1.7 million over a four-year period, starting in April 2022. Tern holds 58.7% of Wyld Networks’ issued share capital, which is quoted on the Nasdaq First North Growth Market in Stockholm.

The Wyld Connect solution being supplied will allow the customer, a South African company, to deploy IoT sensors in the agricultural sector to collect data directly from satellites.

Wyld’s sensor-to-satellite module suite with LoRaWAN®* allows IoT sensors to communicate directly from sensor to Low Earth Orbit satellites or in conjunction with terrestrial LoRa networks. Wyld’s modems, devices, and embedded technology are designed to enable communication with the cloud, no matter the location, providing global IoT coverage.

The UN’s Food and Agriculture Organisation has predicted that global food production in 2050 will need to be 70% higher than in 2009, as the world population grows by over a third, almost all in developing countries. To meet this increase in food demand, agriculture is rapidly adopting IoT sensors and devices to collect data from field to make informed decisions that can increase the yield of crops and reduce the waste of water.

Commenting, Alastair Williamson, CEO of Wyld Networks said: “We are pleased to announce the receipt of these purchase orders. Wyld is actively engaged with customers in piloting the service and as part of our programme we are engaged in commercial discussions to solicit purchase orders with multiple customers for the Wyld Connect IoT module ahead of the commercial launch of the service.”

*The LoRaWAN® specification, developed and maintained by the LoRa Alliance®, is a Low Power, Wide Area networking protocol designed to wirelessly connect battery operated ‘things’ to the internet in regional, national or global networks, and targets key IoT requirements such as bi-directional communication, end-to-end security, mobility and localization services.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Talking Medicines highlights strategic signals emerging across the GLP-1 consumer market

GLP-1 consumers are increasingly weighing access, affordability, quality, clinical oversight and treatment support, creating new strategic considerations across the wider life sciences market.

Tern Plc launches £509,368 underwritten Open Offer

Tern Plc has announced an underwritten Open Offer to raise approximately £509,368 through the issue of 56.6 million shares at 0.90p each. Qualifying shareholders may subscribe for one new share for every 16 shares held, with the offer closing on 22 September 2026.

Talking Medicines targets a growing data need around GLP-1 treatment journeys

Talking Medicines is using GLP-1 discontinuation conversations to show how DrugVoice can help pharmaceutical companies track changing patient needs across the treatment journey.

Device Authority adopts usage-based pricing to support KeyScaler expansion

Device Authority has moved KeyScaler to usage-based pricing, aiming to reduce licensing friction and support broader adoption of its machine identity security platform.

Talking Medicines targets growing demand for GLP-1 patient intelligence

Talking Medicines is using GLP-1 patient conversations to show how behavioural data can help pharmaceutical companies understand changing treatment expectations and engagement.

Talking Medicines builds its AI strategy around specialist life sciences intelligence

Talking Medicines is positioning specialist healthcare intelligence as the core layer that gives agentic AI useful context in life sciences.

Search